16.1 C
Delhi
Wednesday, March 4, 2026

Tag: Indian pharma companies

Mankind Pharma Q3 Profit Jumps 56% to ₹461 Crore, Revenue Up 21%

Mankind Pharma's Q3 FY24 net profit surged 56% year-on-year to ₹460.9 crore, while revenue grew 21.3%. EBITDA margin expanded significantly.

Sun Pharma Q2FY26 Net Profit Rises 2.5% to Rs 3,118 Crore

Sun Pharma reports 9% revenue growth in Q2FY26 with innovative US medicines surpassing generics for the first time. Strong EBITDA margin at 31.3%.